Topic Idarucizumab

Viewing 1–1 of 1

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Treatment with Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran with Idarucizumab: A Case Study
Price: $12.95
Credits:
- ANCC 1.0 CH / 1.0 APH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: JNN0119

Published: Jan 2019

Expires: 12/31/2026

Sources: Journal of Neuroscience Nursing
Details

Required Passing Score: 13/18 (72%)

Authors: Sheila Jala,MHSS MCN; Elizabeth O'Brien, GradDipNeuroSci, MNNP

Categories: Acute Care , Advanced Practice Nursing , Drug Therapy , Neurological

Specialties: Neurology

Topics: Alteplase , Anticoagulation , Dabigatran , Idarucizumab , Stroke , Thrombolytic Therapy

Viewing 1–1 of 1

CEConnection